Evidence map›Paper›PMID 17975745›Full record

ArticleEndocrine2007

Effects of lactogen resistance and GH deficiency on mouse metabolism: pancreatic hormones, adipocytokines, and expression of adiponectin and insulin receptors.

Ramamani Arumugam, Don Fleenor, Michael Freemark

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Endocrine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Growth hormone and adipose tissue: beyond the adipocyte.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2011
    Review
  9. The intricate role of growth hormone in metabolism.Frontiers in endocrinology · 2011
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ramamani ArumugamDepartment of Pediatrics, Duke University Medical Center, Box 3080, Durham, NC 27710, USA. arumu001@mc.duke.edu
Don Fleenor
Michael Freemark
Duke Medical Center · USDuke University Hospital · US

Funding

THE ROLE OF PLACENTAL LACTOGEN IN FETAL DEVELOPMENTR01HD024192 · NICHD · DUKE UNIVERSITY · PI FREEMARK, MICHAEL S. · 1988 to 2007
$2.2M
NICHD NIH HHS HD-24192
6 · The paper itself

Abstract

We recently described a novel mouse model that combines resistance to lactogenic hormones with GH deficiency (GHD). The GHD/lactogen-resistant males develop obesity and insulin resistance with age. We hypothesized that altered production of pancreatic hormones and dysregulation of adipocytokine secretion and action contribute to the pathogenesis of their insulin resistance. Double-mutant males (age 12-16 months) had fasting hyperinsulinemia, hyperamylinemia, hyperleptinemia, and a decreased ratio of adiponectin to leptin. Adiponectin receptor 1 and 2 (AdipoR1 and R2) mRNA levels in liver and skeletal muscle were normal but hepatic insulin receptor mRNA was increased. Relative to double-mutant males, GHD males had lower levels of insulin, amylin, and leptin, higher levels of adiponectin, and higher expression of hepatic AdipoR1 and insulin receptor mRNAs. Lactogen-resistant mice had reduced hepatic adipoR2 mRNA. In response to stress the plasma concentrations of MCP-1 and IL-6 increased in double-mutant males but not GHD or lactogen-resistant males. Our findings suggest that the insulin resistance of GHD/lactogen-resistant males is accompanied by dysregulation of pancreatic hormone and adipocytokine secretion and receptor expression. Phenotypic differences between double-mutant and GHD males suggest that lactogens and GH exert differential but overlapping effects on fat deposition and adipocytokine secretion and action.

Indexed as

AdipokinesAdiponectinAgingAmyloidAnimalsChemokine CCL2Disease Models, AnimalFemaleGrowth HormoneInsulinInsulin ResistanceInterleukin-6Islet Amyloid PolypeptideLeptinMaleMiceAdipokinesAdiponectinAmyloidCcl2 protein, mouseChemokine CCL2Growth HormoneInsulinInterleukin-6Islet Amyloid PolypeptideLeptinPancreatic HormonesProlactinReceptor, InsulinReceptors, Adiponectin

Identifiers

PMID17975745
OpenAlexW1568872241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.